Pfizer vaccine is 94% effective in real-world study
The first big real-world study of the Pfizer/BioNTech vaccine to be independently reviewed shows the shot is highly effective at preventing COVID-19, in a potentially landmark moment for countries desperate to end lockdowns and reopen economies.
Maharashtra Health Minister Rajesh Tope on April 20 informed that the state government has not yet received any letter from Centre about vaccination program for those above 18 years. However, CM Uddhav Thackeray has said that vaccination drive will be conducted in full swing. "Decision has been taken to use imported vaccines Sputnik V, Pfizer," said Rajesh Tope.
The United States is preparing for the possibility that a booster shot will be needed between nine to 12 months after people are initially vaccinated against COVID-19, a White House official said on Thursday. Jayson Albano reports.
Dr. Peter Hotez, co-director of Texas Children’s Hospital’s Center for Vaccine Development says the the clinical trial results of Pfizer/BioNTech’s Covid-19 vaccine showing 100% efficacy in youths ages 12 to 15 is “pretty impressive.”
The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults. A release by Cadila Health said, "The drug has also shown efficacy against other viral infections."Speaking on the development, Dr Sharvil Patel, Managing Director, Cadila Healthcare Limited said: "The fact that we are able to offer a therapy which significantly reduces viral load when given early on can help in better disease management. It comes at a much-needed time for patients and we will continue to provide them access to critical therapies in this battle against COVID-19." This government's approval for use of the antiviral drug comes at a time when India's daily COVID tally is crossing the 3-lakh mark. India recorded 3,32,730 new COVID-19 cases in the last 24 hours, the highest single-day spike since the pandemic broke out last year. India has crossed the mark of 3 lakh COVID-19 cases for two consecutive days now. This has taken the cumulative count of the COVID infection in the country to 1,62,63,695.
Prime Minister Narendra Modi held a meeting with oxygen manufacturers in the country via video-conferencing on April 23. The meeting was attended by Reliance, Tata Steels, SAIL, etc. Requirement of oxygen has soared in hospitals in the country due to COVID situation.
New data proves the Pfizer and Moderna covid vaccines work extremely well in real world conditions. This from the CDC who followed over four thousand healthcare workers for 13 weeks. Among the 2500 of..